Attendees will obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
Dr. Nixon brings unique experience and expertise that is directly relevant to IPA.
The alliance is focused on the discovery of antibodies against three undisclosed therapeutically-relevant ion-channels.
Talem is focused on the discovery and development of fully human therapeutic antibodies.
The Company commences trading under the symbol "IPATF".